Review ArticleClinical Review

Is It Idiopathic Pulmonary Fibrosis or Not?

Mary Salvatore, Genta Ishikawa and Maria Padilla
The Journal of the American Board of Family Medicine January 2018, 31 (1) 151-162; DOI: https://doi.org/10.3122/jabfm.2018.01.170288

References

  1. 1.↵
    1. Wright WC
    1. Ramazzini B
    . Diseases of workers (Wright WC, trans). New York, NY: Hafner; 1964, 243.
  2. 2.↵
    1. Knoll MA,
    2. Salvatore M,
    3. Sheu RD,
    4. et al
    . The use of isodose levels to interpret radiation induced lung injury: A quantitative analysis of computed tomography changes. Quant Imaging Med Surg 2016;6:35–41.
    OpenUrl
  3. 3.↵
    1. Salvatore M,
    2. Henschke CI,
    3. Yip R,
    4. et al
    . Osteophyte induced lung fibrosis prevalence and osteophyte qualities predicting disease. Clin Imag 2017;44:1–4.
    OpenUrl
  4. 4.↵
    1. Simon M,
    2. Potchen EJ,
    3. LeMay M
    1. Liebow AA,
    2. Carrington CB
    . The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers of pulmonary radiology. 1st ed. New York, NY: Grune & Stratton; 1969, 102–141.
  5. 5.↵
    1. Travis WD,
    2. Costabel U,
    3. Hansell DM,
    4. et al
    . An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733–48.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Nathan SD,
    2. Shlobin OA,
    3. Weir N,
    4. et al
    . Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011;140:221–9.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Raghu G,
    2. Chen SY,
    3. Yeh WS,
    4. et al
    . Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: Incidence, prevalence, and survival, 2001–11. Lancet Respir Med 2014;2:566–72.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Raghu G,
    2. Collard HR,
    3. Egan JJ,
    4. et al
    . An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. King TE Jr.,
    2. Pardo A,
    3. Selman M
    . Idiopathic pulmonary fibrosis. Lancet 2011;378:1949–61.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Jo HE,
    2. Corte TJ,
    3. Moodley Y,
    4. et al
    . Evaluating the interstitial lung disease multidisciplinary meeting: A survey of expert centres. BMC Pulm Med 2016;16:22.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Raghu G,
    2. Anstrom KJ,
    3. King TE Jr.,
    4. Lasky JA,
    5. Martinez FJ
    . Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968–77.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Raghu G,
    2. Brown KK,
    3. Bradford WZ,
    4. et al
    . A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125–33.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Noble PW,
    2. Albera C,
    3. Bradford WZ,
    4. et al
    . Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials. Lancet 2011;377:1760–9.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Richeldi L,
    2. Costabel U,
    3. Selman M,
    4. et al
    . Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011;365:1079–87.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Richeldi L,
    2. du Bois RM,
    3. Raghu G,
    4. et al
    . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071–82.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Webb WR,
    2. Muller NL,
    3. Naidich DP
    . High resolution CT of the lung. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2009.
  17. 17.↵
    1. Arakawa H,
    2. Honma K
    . Honeycomb lung: History and current concepts. AJR 2011;196:773–82.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Yamauchi H,
    2. Bando M,
    3. Baba T,
    4. et al
    . Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing. PLoS One 2016;11:e0166168.
    OpenUrl
  19. 19.↵
    1. Raghu G,
    2. Wells AU,
    3. Nicholson AG,
    4. et al
    . Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am J Respir Crit Care Med 2017;195:78–85.
    OpenUrl
  20. 20.↵
    1. Bjoraker JA,
    2. Ryu JH,
    3. Edwin MK,
    4. et al
    . Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199–203.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Nicholson AG,
    2. Colby TV,
    3. du Bois RM,
    4. Hansell DM,
    5. Wells AU
    . The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213–7.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Daniil ZD,
    2. Gilchrist FC,
    3. Nicholson AG,
    4. et al
    . A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899–905.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Nagai S,
    2. Kitaichi M,
    3. Itoh H,
    4. Nishimura K,
    5. Izumi T,
    6. Colby TV
    . Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010–9.
    OpenUrlAbstract
  24. 24.↵
    1. Arakawa H,
    2. Yamada H,
    3. Kurihara Y,
    4. et al
    . Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 2003;123:1096–103.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Kim DS,
    2. Yoo B,
    3. Lee JS,
    4. et al
    . The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002;9:121–7.
    OpenUrl
  26. 26.↵
    1. Yamadori I,
    2. Fujita J,
    3. Bandoh S,
    4. et al
    . Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002;22:89–92.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Fischer A,
    2. Antoniou KM,
    3. Brown KK,
    4. et al
    . An official European Respiratory Society/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features. Eur Respir J 2015;46:976–87.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Belloli EA,
    2. Beckford R,
    3. Hadley R,
    4. Flaherty KR
    . Idiopathic non-specific interstitial pneumonia. Respirology 2016;21:259–68.
    OpenUrl
  29. 29.↵
    1. Travis WD,
    2. Hunninghake G,
    3. King TE Jr.,
    4. et al
    . Idiopathic nonspecific interstitial pneumonia: Report of an American Thoracic Society project. Am J Respir Crit Care Med 2008;177:1338–47.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Park IN,
    2. Jegal Y,
    3. Kim DS,
    4. et al
    . Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009;33:68–76.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Lee JY,
    2. Jin SM,
    3. Lee BJ,
    4. Chung DH,
    5. et al
    . Treatment response and long term follow-up results of nonspecific interstitial pneumonia. J Korean Med Sci 2012;27:661–7.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Smith ML
    . Update on pulmonary fibrosis: Not all fibrosis is created equally. Arch Pathol Lab Med 2016;140:221–9.
    OpenUrl
  33. 33.↵
    1. Johkoh T
    . Nonspecific interstitial pneumonia and usual interstitial pneumonia: Is differentiation possible by high-resolution computed tomography? Semin Ultrasound CT MR 2014;35:24–8.
    OpenUrl
  34. 34.↵
    1. Trahan S,
    2. Hanak V,
    3. Ryu JH,
    4. Myers JL
    . Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: Analysis of 31 biopsies from 15 patients. Chest 2008;134:126–32.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Ohtani Y,
    2. Saiki S,
    3. Kitaichi M,
    4. et al
    . Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005;60:665–71.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Churg A,
    2. Sin DD,
    3. Everett D,
    4. Brown K,
    5. Cool C
    . Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 2009;33:1765–70.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Lima MS,
    2. Coletta EN,
    3. Ferreira RG,
    4. et al
    . Subacute and chronic hypersensitivity pneumonitis: Histopathological patterns and survival. Respir Med 2009;103:508–15.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Gaxiola M,
    2. Buendía-Roldán I,
    3. Mejía M,
    4. et al
    . Morphologic diversity of chronic pigeon breeder's disease: Clinical features and survival. Respir Med 2011;105:608–14.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Vourlekis JS,
    2. Schwarz MI,
    3. Cool CD,
    4. et al
    . Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002;112:490–3.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.
    1. Salisbury ML,
    2. Myers JL,
    3. Belloli EA,
    4. Kazerooni EA,
    5. Martinez FJ,
    6. Flaherty KR
    . Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. Am J Respir Crit Care Med. 2017;196:690–9.
    OpenUrl
  41. 41.↵
    1. Torres PP,
    2. Moreira MA,
    3. Silva DG,
    4. da Gama RR,
    5. Sugita DM,
    6. Moreira MA
    . High-resolution computed tomography and histopathological findings in hypersensitivity pneumonitis: A pictorial essay. Radiol Bras 2016;49:112–6.
    OpenUrl
  42. 42.↵
    1. Park WH,
    2. Kim SS,
    3. Shim SC,
    4. et al
    . Visual Assessment of chest computed tomography findings in anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis: Is it associated with airway abnormalities? Lung 2016;194:97–105.
    OpenUrl
  43. 43.↵
    1. Rybicki BA,
    2. Major M,
    3. Popovich J Jr.,
    4. et al
    . Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234–241.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Baughman RP,
    2. Teirstein AS,
    3. Judson MA,
    4. et al
    . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164(10 Pt 1):1885–9.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Patterson KC,
    2. Strek ME
    . Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc 2013;10:362–70.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Ramachandraiah V,
    2. Aronow W,
    3. Chandy D
    . Pulmonary sarcoidosis: An update. Postgrad Med 2017;129:149–158.
    OpenUrl
  47. 47.↵
    1. Nunes H,
    2. Humbert M,
    3. Capron F,
    4. et al
    . Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis. Thorax 2006;61:68–74.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Teirstein AT,
    2. Morgenthau AS
    . “End-stage” pulmonary fibrosis in sarcoidosis. Mt Sinai J Med 2009;76:30–6.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Hansell DM,
    2. Milne DG,
    3. Wilsher ML,
    4. Wells AU
    . Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998;209:697–704.
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    1. Criado E,
    2. Sánchez M,
    3. Ramírez J,
    4. et al
    . Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010;30:1567–86.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Pollack A
    . F.D.A. approves first 2 drugs for treatment of a fatal lung disease. NY Times. October 14, 2014.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords